title: Butyrate modulates surfactant protein mRNA in fetal rat lung by altering mRNA transcription and stability.
abstract: We examined the effects of Na butyrate, a known regulator of gene expression, on surfactant protein mRNA concentration, transcription, and degradation. Exposure of explants of 18-day fetal rat lung to Na butyrate resulted in a decrease in surfactant protein A (SP-A) mRNA concentration to 7% of control after 6 h and to 18% of control after 24 h. The reduction in SP-A mRNA concentration was associated with decreased mRNA transcription and stability at both these times. The effects on SP-B mRNA were similar to those on SP-A, but quantitatively less. In contrast, butyrate had a biphasic effect on SP-C mRNA concentration. There was an initial decrease to 30% of control at 6 h, followed by an increase to control levels by 24 h. Transcription of SP-C was increased at both these times, whereas degradation was enhanced at 6 h, but not at 24 h. The level of surfactant protein mRNA after butyrate treatment therefore depends on the balance between induced changes in transcription and degradation. Butyrate had no effect on gamma-actin mRNA concentration in this system. Circulating levels of butyric acid analogues are elevated in the mothers and fetuses in diabetic pregnancies. Some of these fetuses have delayed lung maturation and decreased amniotic fluid SP-A levels. We speculate that butyric acid analogues partially mediate the changes in pulmonary maturation induced by maternal diabetes.
authors.affiliation: Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510.
authors.forename: S M
authors.initials: SM
authors.lastname: Peterec
authors.forename: K V
authors.initials: KV
authors.lastname: Nichols
authors.forename: D W
authors.initials: DW
authors.lastname: Dynia
authors.forename: C M
authors.initials: CM
authors.lastname: Wilson
authors.forename: I
authors.initials: I
authors.lastname: Gross
mesh_terms: D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D020148:Butyric Acid; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D008168:Lung / Q000196:embryology*; D011510:Proteolipids / Q000235:genetics* / Q000378:metabolism; D037662:Pulmonary Surfactant-Associated Protein A; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D051381:Rats; D013997:Time Factors; D014158:Transcription, Genetic
chemical_list: D002087:Butyrates; D011510:Proteolipids; D037662:Pulmonary Surfactant-Associated Protein A; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants; D012333:RNA, Messenger; D020148:Butyric Acid